ad

Addus HomeCare

ADUS
NASDAQ
$106.51

Addus HomeCare a-t-elle un rempart concurrentiel (moat) solide ?

Addus benefits from scale in a fragmented, operationally intensive niche where compliance, billing, scheduling, and managed-care contracting capabilities matter.

The 2024 Gentiva personal care acquisition and 2025–2026 tuck-ins broadened density and payer reach, and offering three levels of care in select markets increases negotiating leverage and cross-referrals.

Nonetheless, switching costs for consumers are moderate, network effects are limited, and state-set or plan-set pricing constrains classical pricing power.

Moat sub-scores and weights we apply: cost advantage 75/100 (30 percent weight) via SG&A leverage and shared back office; switching costs 65/100 (30 percent) given caregiver-client relationships and MCO contracting frictions; intangible assets 65/100 (20 percent) including state relationships/licensure and reputation; efficient scale 70/100 (10 percent) in certain local markets; network effects 20/100 (10 percent).

Weighted result about 64. Future moat trajectory depends on building deeper multi-service density and value-based contracts.